1. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis1899; 17: 543-550.
2. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-1330.
3. Dubaniewicz A, Kampfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb) 2006; 86: 60-67.
4. Baughman RP1, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1885–1889.
5. Adams JS, Singer FR, Gacad MA, Sharma OP, Hayes MJ, Vouros P, et al. Isolation and structural identification of 1, 25âdihydroxyvitamin D produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab1985; 60: 960–965.
6. Fluschnik N1, Lund G1, Becher PM1, Blankenberg S1, Muellerleile K, et al. Fulminant isolated cardiac sarcoidosis with pericardial effusion and acute heart failure: Challenging aspects of diagnosis and treatment. World J Clic Cases 2016; 4(3):76-80.
7. Pierre Louis B, Prasad A, Frishman WH. Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol rev 2009:17(4)15.
8. Garret J, O’Neill H, Blake S. Constrictive pericarditis associated with sarcoidosis. Am Heart J.1984; 107(2):394.
9. Uysal N, Ptacin M, Schapira R. Sarcoidosis of the pericardium: clinical observations and review. Clinical Pulmonary medicine. 2002; 9:177-181.
10. Angomachalelis N1, Hourzamanis A, Salem N, Vakalis D, Serasli E, Efthimiadis T, et al. Pericardial effusion concomitant with specific heart muscle disease in systemic sarcoidosis. Postgrad Med J 1994; 70(1):S8-S12.
11. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation.1978; 58(6):1204-1211.
12. Pesola G, Teirstein AS, Goldman M. Sarcoidosis presenting with pericardial effusion. Sarcoidosis. 1987; 4: 42–44.
13. Darda S, Zughaib ME, Alenxander PB, Machado C E, David S W, Saba S. Cardiac sarcoidosis presenting as constrictive pericarditis. Ex Heart Inst J 2014: 41(3); 319-323.
14. Smith-Rohrberg D, Sharma SK. Tuberculin skin test among pulmonary sarcoidosis patients with and without tuberculosis: It’s utility for the screening of the two condition sin tuberculosis Endemic regions. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 130-134.
15. Weiner R,Hoffer PB, Thakur ML. Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. J Nucl Med 1981; 22:32–37.
16. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31:1909–1914.
17. Kurdziel KA. The panda sign. Radiology 2000; 215:884–885.
18. O'Connell JB, Robinson JA, Henkin RE, Gunnar RM. Gallium 67-citrate scanning for noninvasive detection of inflammation in pericardial diseases. Am J Cardiol.1980; 46: 879-884.
19. Taillefer R, Daniel D. Gallium67 uptake by the heart. Seminars in Nucl Med.1983; 13(2):176-178.
20. J. Gaál, I. Hegedüis, K. Dévényi, and L. Czirják, “Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis,” Annals of the Rheumatic Diseases1995; 54:856–858.
21. Mochizuki T, Tsukamoto E, Kuge Y et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med2001; 42:1551–1555.
22. Keijsers RG, Grutters JC, Thomeer M, et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67 Ga imaging and 18 F-FDG PET. Q J Nucl Med Mol imaging 2011; 55: 66–71.
23. Strobel K, Schuler R, Genoni M. Visualization of pericarditis with fluoro-deoxy-glucose-positron emission tomography/computed tomography. Eur Heart J 2008; 29(9):1212.
24. Mirakhur A, Anca N, Mikami Y, et al. T2-weighted imaging of the heart--a pictorial review. Eur J Radiol 2013; 82:1755–1762.
25. Takakura H, Sunada K, Shimizu K. Tubercular constrictive pericarditis detected on positron emission tomography. Kekkaku 2016; 91(2):65-68.
26. Wyplosz B, Marijon E, Dougados J, Pouchot J. Sarcoidosis an unusual cause of pericarditis.Acta Cardiol 2010; 65(1):83-84.
27. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88(9):1006-1010.
28. Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation 1999; 100(13): 1380-1386.
29. Bertog SC1, Thambidorai SK, Parakh K, Schoenhagen P, Ozduran V, Houghtaling PL, et al. Constrictive pericarditis: etiology and cause- specific survival after pericardiectomy. J Am Coll Cardiol 2004; 43(8):1445-1452.